Search Results - "Ke, Shizhong"

Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer by Dang, Fabin, Nie, Li, Zhou, Jin, Shimizu, Kouhei, Chu, Chen, Wu, Zhong, Fassl, Anne, Ke, Shizhong, Wang, Yuangao, Zhang, Jinfang, Zhang, Tao, Tu, Zhenbo, Inuzuka, Hiroyuki, Sicinski, Piotr, Bass, Adam J., Wei, Wenyi

“…Although inhibitors targeting CDK4/6 kinases (CDK4/6i) have shown promising clinical prospect in treating ER+/HER2- breast cancers, acquired drug resistance is…”
Get full text

Reciprocal antagonism of PIN1-APC/CCDH1 governs mitotic protein stability and cell cycle entry by Ke, Shizhong, Dang, Fabin, Wang, Lin, Chen, Jia-Yun, Naik, Mandar T., Li, Wenxue, Thavamani, Abhishek, Kim, Nami, Naik, Nandita M., Sui, Huaxiu, Tang, Wei, Qiu, Chenxi, Koikawa, Kazuhiro, Batalini, Felipe, Stern Gatof, Emily, Isaza, Daniela Arango, Patel, Jaymin M., Wang, Xiaodong, Clohessy, John G., Heng, Yujing J., Lahav, Galit, Liu, Yansheng, Gray, Nathanael S., Zhou, Xiao Zhen, Wei, Wenyi, Wulf, Gerburg M., Lu, Kun Ping

“…Induced oncoproteins degradation provides an attractive anti-cancer modality. Activation of anaphase-promoting complex (APC/C CDH1 ) prevents cell-cycle entry…”
Get full text

Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy by Koikawa, Kazuhiro, Kibe, Shin, Suizu, Futoshi, Sekino, Nobufumi, Kim, Nami, Manz, Theresa D., Pinch, Benika J., Akshinthala, Dipikaa, Verma, Ana, Gaglia, Giorgio, Nezu, Yutaka, Ke, Shizhong, Qiu, Chenxi, Ohuchida, Kenoki, Oda, Yoshinao, Lee, Tae Ho, Wegiel, Babara, Clohessy, John G., London, Nir, Santagata, Sandro, Wulf, Gerburg M., Hidalgo, Manuel, Muthuswamy, Senthil K., Nakamura, Masafumi, Gray, Nathanael S., Zhou, Xiao Zhen, Lu, Kun Ping

“…Pancreatic ductal adenocarcinoma (PDAC) is characterized by notorious resistance to current therapies attributed to inherent tumor heterogeneity and highly…”
Get full text

PARP-inhibition reprograms macrophages toward an anti-tumor phenotype by Wang, Lin, Wang, Dan, Sonzogni, Olmo, Ke, Shizhong, Wang, Qi, Thavamani, Abhishek, Batalini, Felipe, Stopka, Sylwia A., Regan, Michael S., Vandal, Steven, Tian, Shengya, Pinto, Jocelin, Cyr, Andrew M., Bret-Mounet, Vanessa C., Baquer, Gerard, Eikesdal, Hans P., Yuan, Min, Asara, John M., Heng, Yujing J., Bai, Peter, Agar, Nathalie Y.R., Wulf, Gerburg M.

“…Poly(ADP)ribosylation inhibitors (PARPis) are toxic to cancer cells with homologous recombination (HR) deficiency but not to HR-proficient cells in the tumor…”
Get full text

Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations by Ke, Shizhong, Chen, Shuzhen, Dong, Zihui, Hong, Christopher S., Zhang, Qi, Tang, Liang, Yang, Pinghua, Zhai, Jian, Yan, Hexin, Shen, Feng, Zhuang, Zhengping, Wen, Wen, Wang, Hongyang

“…Erythrocytosis is a common paraneoplastic syndrome associated with hepatocellular carcinoma. Although increased erythropoietin (EPO) is found in these…”
Get full text

Reciprocal antagonism of PIN1-APC/C CDH1 governs mitotic protein stability and cell cycle entry by Ke, Shizhong, Dang, Fabin, Wang, Lin, Chen, Jia-Yun, Naik, Mandar T, Li, Wenxue, Thavamani, Abhishek, Kim, Nami, Naik, Nandita M, Sui, Huaxiu, Tang, Wei, Qiu, Chenxi, Koikawa, Kazuhiro, Batalini, Felipe, Stern Gatof, Emily, Isaza, Daniela Arango, Patel, Jaymin M, Wang, Xiaodong, Clohessy, John G, Heng, Yujing J, Lahav, Galit, Liu, Yansheng, Gray, Nathanael S, Zhou, Xiao Zhen, Wei, Wenyi, Wulf, Gerburg M, Lu, Kun Ping

“…Induced oncoproteins degradation provides an attractive anti-cancer modality. Activation of anaphase-promoting complex (APC/C ) prevents cell-cycle entry by…”
Get full text

Study of a single airport ground-holding model by Wanglai Jun, Shizhong Ke

“…Ground-holding is an important method to cater for the predicted capacity problem, its purpose is to low the cost of congestion in the air traffic flow…”
Get full text